Streptolysin S (SLS) is the extracellular, nonantigenic, oxygen-insensitive hemolysin produced by streptococci of group A and some other serological groups, which is dependent for activity on the presence of various stabilizing carriers such as albumin, Tween, yeast ribonucleic acid (RNA), or the yeast RNA-core resistant to pancreatic ribonuclease (8, 20, 24 , 35 for reviews). Because of this instability, purification of the hemolysin has been based on methods for purification of the carriers. On the basis of such procedures, it has been reported that extracellular SLS is a peptide with a molecular weight of approximately 2,800 (9) , which can be transferred from one carrier to another (20, 23) . Most commonly, extracellular SLS is obtained as "RNA-core SLS," produced on incubation of resting cells of group A streptococci in pH 7 .0 phosphate buffer containing Mg2+, maltose, RNA-core, and cysteine (23, 26) or thioglycolate (7) . A lag period characteristically precedes the initiation of hemolysis (6) .
Cellular hemolysins of group A streptococci related in properties to extracellular SLS have also been described. A hemolysin released by prolonged sonication was found by Schwab to be similar to RNA-core SLS in stability, kinetics of hemolysis, and sensitivity to inhibitors (38, 39) but different in monovalent ion effects and susceptibility of erythrocytes of different species (38) , as well as in weak antigenicity in rabbits (40) . The hemolytic activity obtained by sonicating or grinding streptococcal cells was reported by Taketo and Taketo not only to be similar in properties to SLS, but also to be transferable to RNA-core on incubation, with an increase in titer (44) (45) (46) . A cell-bound hemolysin, demonstrable only with intact streptococcal cells, has been shown by Ginsburg and co-workers to be present in strains capable of producing extracellular SLS (21, 22) . Several investigators have treated group A streptococci with phage-derived muralysin (29, 32) to obtain protoplasts, cell ghosts, or protoplast membranes and have demonstrated formation or release of SLS-like hemolysin on incubation of these cellular compo,nents with RNA-core (28, 33, (41) (42) (43) . None of these last investigators reported the presence of cellular hemolysin active without such incubation, although the lysates do not appear to have been tested for activity.
Although the cellular origin of the extracellular hemolysin has not been definitively ascertained, it would seem possible that the intracellular, membrane-associated and surfaceassociated hemolysins might represent precursor stages in the production of extracellular SLS. In our investigations on the biosynthesis of SLS, we have found, and report in this paper, that rupture of group A streptococci by phagederived muralysin results in the release of both a labile active hemolysin and a stable inactive potential hemolysin which can be activated simply by sonication with RNA or RNA-core to yield high-titer stable active hemolysin. Both active hemolysins have characteristics of SLS.
MATERIALS AND METHODS Growth procedures. Streptococcus pyogenes C203S (obtained from Alan Bernheimer) was maintained in stock culture on blood agar slants. A three-step growth procedure was used.
Step (i) Streptococci from a slant were inoculated into 5 ml of brain heart infusion broth (Difco) and incubated for 17 to 21 h.
Step (ii) One milliliter of the brain heart infusion culture was inoculated into 180 ml of brain heart infusion containing 0.7% glucose and incubated for 13 to 15 h. These cells were then centrifuged at 2,000 x g for 15 min at room temperature, washed once with 37-C heart infusion broth (HI; Difco), and suspended in 8 ml of HI.
Step (iii) An appropriate number of replicate final cultures were made by inoculating 1 ml of the suspension into 100 ml of HI supplemented with 0.3% maltose per 250-ml Erlenmeyer flask and incubating for the appropriate time. All incubations were at 37 C under stationary conditions. After incubation, the flasks were cooled in an ice bath for 5 min, and the cultures were centrifuged at 5,000 x g for 10 min. The cells from each flask were washed once with 100 ml of sterile saline solution and then suspended in 1 to 2 ml of 0.03 M sodium phosphate buffer (pH 6.5) containing 0.85% NaCl.
Disruption of the cells. (i) Sonication. No more than 6 ml of a suspension of bacteria in buffer was sonicated at one time. The usual volume was 3 ml. The bacteria surrounded by an ice bath were sonicated for 20 to 25 min with the Bronwill Biosonic sonicator (model BP-1) at a power intensity of 75 or for 20 min with the Bronwill Biosonic sonicator (model 2) at a power intensity of 60. The probe was water cooled during operation and cooled in an ice slurry before use. The sonicate was centrifuged at 20,000 x g and 4 C for 30 min, and the sediment was discarded.
(ii) Muralysin. Heavy bacterial suspensions were incubated for 20 min at 23 C with the muralysin preparation described below. The number of muralysin units to be added to each suspension was calculated by the following formula: 32 units x milliliters of suspension x optical density of the suspension at 520 nm. The debris was removed by centrifugation at 20,000 x g and 4 C for 30 min to obtain muralysintreatment supernatant.
Preparation of muralysin. Muralysin was prepared from a phage lysate of group C streptococci. Both the streptococcal culture and the phage were obtained from H. L. Torney of Dow Chemical Co. The method of Fox (19) was employed, with the following modifications in the preparation and titering of the phage of high titer. The high-titer phage preparation was obtained by infecting 1 liter containing 4 x 1011 log-phase bacteria with 8 x 10'0 plaque-forming units, allowing lysis to occur, removing the bacterial debris by centrifugation at 3,600 x g for 10 min, sedimenting the phage by centrifugation at 100,000 x g and 4 C for 2 h, and suspending the phage pellets in 5 ml of Todd-Hewitt broth. The phage preparation was titered by lawning 0.2 ml of log-phase group C streptococci over Todd-Hewitt agar plates previously dried overnight, incubating the plates 1 h at 37 C, and then spreading 0.05 ml of phage dilutions on the lawn. Plaques were counted after 8 h at 37 C. The phage suspension as prepared above had a titer of 4.5 x 1011 plaque-forming units/ml. The muralysin was titered by the method of Markovitz and Dorfman (31) .
Preparation of streptococcal RNA. S. pyogenes C203S cells were grown for 4.5 or 8.5 h in step (iii), washed, and disrupted with muralysin. All subsequent procedures except shaking were done in an ice bath or under refrigeration. To the streptococcal lysate was added an equal volume of phenol, washed and equilibrated with the buffered saline solution used for bacterial suspension. The mixture was vigorously shaken for 5 min and centrifuged at 10,000 x g for 15 min. Phenol extraction of the aqueous layer was repeated four times. The preparation was washed three times with ether to remove phenol and then gassed with N2 for 30 min to remove ether. Two volumes of 100% ethanol was added, and the preparation was stored at -20 C. The nucleic acid precipitate was suspended in appropriate buffer as required.
One optical density unit is that amount in 1.0 ml of distilled H2O which will yield an optical density at 260 nm of 1.0 (1-cm light path).
Preparation of RNA-core. Yeast RNA (Schwartz) was digested with pancreatic ribonuclease (Sigma) by the procedure of Ginsburg and Harris (23) . The dialysis retentate was lyophilized and stored at -20 C.
Preparation of RNA-core SLS. The procedure of Bernheimer (7) as modified by Ginsburg and Harris (23) was used to prepare RNA-core SLS from resting cells incubated in Bernheimer's basal medium.
Assay of hemolysin. The assay procedure was a modification of that used by Schwab (38 (17) or as follows. Packed RBC (8 ml) were lysed in 40 ml of distilled H20. The lysate was centrifuged at 20,000 x g for 20 min, and the supernatant was discarded. The pellet was washed alternately with distilled H2O and saline until the supernatant was colorless, which required four to five washes. The final pellet of membranes was suspended in 5 ml of saline solution, and the occasional small amount of nondispersible material was discarded. The membrane preparations were stored at -20 C.
Adsorption with RBC membranes. RBC membranes, prepared as described above, were used for treatment of hemolysin preparations. Packed RBC membranes (0.2 to 0.5 ml) were mixed with the appropriate hemolysin preparation ( 
RESULTS
The growth system described in Materials and Methods was developed to utilize the inhibitory effect of glucose on RNA-core SLS production (36) and the stimulatory effect of maltose (14) shown in Table 1 . A large population of glucose-inhibited strain C203S cells could be obtained from step (ii) for the initiation of step (iii) in HI-0.3% maltose, which medium supported both excellent growth and hemolysin yields. Ohtsuki (34) has reported similar relationships of maltose to growth and extracellular RNA-core SLS yields. Since the extracellular hemolytic activity produced in the absence of RNA-core was totally inhibited by cholesterol (0.5 mg/ml) and unaffected by trypan blue (13 .tg/ml), it was apparently due entirely to SLO (6, 11) .
When cells harvested during step (iii) growth were sonicated, sonically released hemolysin, characterized by a lag in onset of hemolysis, was first detected during the lag phase, increased in titer until the beginning of stationary phase, and decreased in titer thereafter (Fig. 1) . Such sonically released hemolysin (SS hemolysin) was not found in cells grown in the presence of glucose. The titers of both the SS hemolysin and RNA-core SLS was depressed by the presence of glucose during growth and were similarly related to the growth cycle. (Fig. 2) . This difference was not due to the muralysin preparations, which had neither hemolytic activity nor ability to abolish the lag in SS hemolysis. In agreement with similar findings by Taketo and Taketo (46) , it seemed most probable that the hemolytic activity initiated without lag was due to SLO (6) . Attempts to unmask an SLS-like hemolysin by inhibition of SLO with cholesterol (0.1 mg/ml) or anti-SLO (0.1 Todd unit/30 HU) were complicated by the fact that both of these agents at the concentrations used also had some inhibitory activity on the delayed hemolysis by preparations of SS and RNA-core SLS. More clear-cut differential inhibition was achieved by the use of N-ethylmaleimide, a compound reacting with sulfhydryl groups, which have been implicated by many studies to be essential for SLO activity. At (Fig. 3 ) and like the sonication supematant (Fig. 2) , and in some preparations was of considerable magnitude. For example, one MS preparation from late log-phase cells contained about 190 HU of fast hemolysin per ml and about 60 HU of delayed hemolysin per ml remained after adsorption with either sheep RBC or sheep RBC. membranes. The hemolytic activity in MSm was clearly different from that shdwn by unadsorbed MS, since the titer and kinetics of hemolysis by MSm were unaffected by the-addition of 20 mM N-ethylmaleimide, and the hemolytic activity, like RNA-core SLS, was totally inhibited by trypan blue at 13 lsg/ ml, a concentration which only slightly inhibited hemolysis by commercial SLO or unadsorbed MS.
The MSm hemolysin in these preparations was very labile, even in the cold; it had a half-life of about 4 h when the cell lysates were maintained in an ice bath. In contrast, neither RNA-core SLS nor the cellular delayed hemolysin in SS lost activity on storage in ice for as long as 24 h. The similarity in kinetics of hemolysis and trypan blue sensitivity between RNA-core SLS and MSm hemolysin suggested that the latter might also be stabilized by RNA-core. Such stabilization was demonstrable on incubation of MSm hemolysin at 37 C with varying concentrations of RNA-core in Bemheimer basal medium (Fig. 4A ) or in the unsupplemented standard phosphate buffer. The lower activity in the presence of 3.0 mg of RNA-core per ml may be comparable to the inhibition of RNA-core SLS by excess core (27) . Although the rate of decay at 0 C was much slower than at 37 C, no stabilizing effect of RNA-core at the lower temperature was detectable. It was of interest that SS hemolysin, which was quite stable at 0 C in the absence of exogenous RNA-core, decayed rapidly at 37 C unless RNA-core was present (Fig. 4B) .
Although the lability of MSm hemolysin in the absence of RNA-core precluded detailed characterization or purification, a few other properties could be estimated. Of the activity recoverable after (NH4) 2SO fractionation, about one-third was precipitated at 50% saturation; and a small fraction of the remainder was detected in the precipitate at 75% saturation. RNA-core SLS is not precipitated by these concentrations of (NH)2SO4. If Schwab (38) , indicating increase in titer of intracellular hemolysin on prolonged sonication of streptococci, similarly suggested activation of a latent hemolysin. Sonication of MSm preparations resulted in some cases (e.g., Table  2 , experiment 1) in a several-fold increase in hemolysin titer, whereas in a few cases (e.g., Table 2 , experiment 2) no increase occurred; the usual titer increase was about 1.5-to 2-fold. However, sonication of MSm in the presence of RNA-core markedly increased the titer above that obtained by sonication of MSm alone and was particularly effective when no titer increase occurred on sonication in the absence of added RNA ( Table 2 ). It was necessary that RNA-core be present during the initial sonication of MSm; once MSm was sonicated, no further activation was obtained by either addition of, or sonication with, RNA-core. Bernheimer and Rodbart (14) had found that addition of endogenous RNA to streptococcal cultures increased the titer of extracellular SLS. Since endogenous RNA might also function in the titer increase on sonication, whether RNA-core was present or not, the effect of RNA extracted from early log phase (4.5 h) and late log phase (8.5 h) S. pyogenes C203S cultures was examined ( Table  2 ). The RNA preparation from 8.5-h cells was more effective than an equivalent amount of RNA preparation from 4.5-h cells, although it should be noted that the equivalency was based on optical density readings, which may not be a valid criterion. The presence of appropriate endogenous RNA in an MSm preparation might therefore be necessary for activation of potential hemolysin on sonication when RNA-core was not added. However (27) . To obtain the maximal titer of potential hemolysin, it was also necessary to use appropriate volumes for sonication, to control (Fig. 6A) with 20% recovery, but after sonication of the precipitate with RNA-core the activated hemolysin was eluted between 34 to 86 ml after the void volume ( 4-core concen-active hemolysin, which had an elution volume ng/ml. Titers 50 ml greater than that of the potential hemoly-,350; MSm+s, sin. Furthermore, the elution profile of the activated hemolysin was like that of RNA-core SLS (Fig. 6C) . These data support the hypotheo select the sis that the potential hemolysin when sonicated sonicate for with RNA-core is activated to a hemolysin in- 6 . Sephadex G-100 chromatography of potential hemolysin, activated hemolysin, and RNA-core SLS. (A) Potential hemolysin: 40% saturated ammonium sulfate-precipitated potential hemolysin preparation (2.6 mg of protein; equivalent to 2,400 HU after activation) in 2 ml of standard buffer containing 180 mg of sucrose was applied to a Sephadex G-100 column (2.5 by 45 cm) and eluted with standard buffer. Fractions were assayed for potential hemolysin (A) by determination of the hemolysin titer after sonication of 1.5 ml of eluate + 2 mg of RNA-core + 3 x 10-4 M Mg2+ in standard buffer to 3.0 ml (final volume) for 20 original sonication with the model 2 instru-original SSm with RNA-core had no effect, but ment had not effectively inactivated SLO or similar incubation of resonicated SSm resulted activated potential hemolysin. Incubation of in an increase in titer (Table 3) have been due to greater stability of the resultant hemolysin at the assay temperature of 37 C. These results clearly indicate that only active hemolysin is transferred to, or stabilized by, RNA-core, and that potential hemolysin cannot be activated simply by incubation with RNA-core.
SS preparations contained two active hemolysins separable by Sephadex G-100 chromatography: a minor peak eluting at the void volume and a major peak (17 ml after the void volume) containing a hemolysin with characteristics of SLO, i.e., hemolysis without lag, inhibition by cholesterol, and lability in the absence of reducing agents. As expected, the second peak was absent from elution profiles of SSm. Both the potential hemolysin in SSm and the activated hemolysin in resonicated SSm eluted at the void volume. This activated hemolysin was like the active SS hemolysin eluting at the void volume in exhibiting delayed-type hemolysis and in pattern of susceptibility to inhibitors. More than 90% of the SS hemolysin activity was lost on the column. In contrast, the hemolysin resulting from incubation of resonicated SSm with RNA-core eluted at the same position as RNA-core SLS (Fig. 6C) , with approximately 90% recovery, and was as resistant to inactivation at 37 C and as sensitive to inhibition by trypan blue as RNA-core SLS. Thus, not only the hemolysin produced by sonication of potential hemolysin with RNAcore, but also the hemolysin resulting from incubation of SS hemolysin with RNA-core exhibit patterns identical to those of RNA-core SLS in elution volume and good recovery on Sephadex G-100 chromatography, sensitivity to trypan blue, lag in onset of hemolysis, and stability at 37 C. While SS hemolysin resembled the above hemolysins in sensitivity to trypan blue and lag in onset of hemolysis, it differed markedly in its elution at the void volume and poor recovery on Sephadex G-100 chromatography, and also in being about twice as sensitive to inactivation at 37 C.
Chromatography of SS hemolysin and potential hemolysin on a Sephadex G-200 column also resulted in elution of both in the void volume, indicating molecular weights greater than 200,000. The molecular weight of RNAcore SLS was estimated from the elution volume (Fig. 6C) to be equivalent to that of a protein of 18,500 molecular weight, as determined by the method of Andrews (2) with bovine serum albumin, ovalbumin, chymotrypsinogen A, and myoglobin as markers. Since the standards should have included RNA-protein complexes of different sizes, the molecular weights of the RNA-core SLS and the RNAcore-associated cellular hemolysins could therefore be only roughly estimated as 18,500.
Unfortunately, the active hemolysin in unsonicated MSm preparations (LACH) was too labile to survive gel chromatography, so that no estimate of the molecular weight of endogenously activated hemolysin could be derived. However, LACH stabilized by RNA-core was eluted from Sephadex G-100 at the same elution volume as RNA-core SLS, like the other RNAcore-stabilized SLS-related cellular hemolysins described above.
Sensitivity to enzymes and solvents. Sonication not only changed the size of precursor hemolysin during activation in the presence of RNA-core, but also changed the susceptibility to inactivation by proteolytic enzymes and organic solvents. Potential hemolysin (350 potential HU) was incubated with Pronase (0.5 mg/ml) or trypsin (0.4 mg/ml) at 37 C for 30 min at pH 8.0. The preparations were then activated by sonication at pH 6.5 with 6 mg of RNA-core and 3 x 10-4 M Mg2+ for 25 min and then assayed. Activated hemolysin (300 HU) was incubated similarly with trypsin at pH 7.8 and at pH 7.2 with Pronase and assayed at pH 6.5. Although both potential and preactivated hemolysin were inactivated by incubation with Pronase, a control Pronase solution which had been incubated at 37 C for 30 min and sonicated for 25 min had no effect on pre-activated hemolysin. Thus, the Pronase effect on potential hemolysin was apparently mediated before sonication. Potential hemolysin was also sensitive to trypsin (only 14% potential activity remained), whereas activated hemol-VOL. 12, 1975 Heterogeneity of the potential hemolysin material was demonstrated by the pattern of sedimentation through a sucrose gradient (Fig. 7) . The majority of the potential hemolysin preceded the bulk of material adsorbing at 260 and 280 nm; some sedimented through the gradient and was recovered in the insoluble material at the bottom of the tube. SS hemolysin was also heterogeneous when sedimented through a sucrose gradient, extending throughout the gradi- ent, but the bulk of the hemolysin was located in the middle region of the gradient and none pelleted at the bottom of the tube (Fig. 8) out RNA-core. Very little increase in titer occurred on resonication with RNA-core, indicating that most of the potential hemolysin had already been activated during treatment in the Braun homogenizer, or was otherwise lost. Sonically released hemolysin and hemolysin released by homogenization were then similar in delayed hemolysis, inhibition by trypan blue, stability in the cold, and rate of inactivation at 37 C. The activation of potential hemolysin by homogenization might explain why Taketo and Taketo (44) obtained what was probably the activated form of potential hemolysin (SS hemolysin) from both sonicated and ground group A streptococci.
Effect of glucose on potential hemolysin and RNA-core SLS production. Experimental data relevant to the hypothesis that potential hemolysin is precursor to RNA-core SLS were obtained by utilizing the effect of glucose on both. Glucose markedly decreased the production of RNA-core SLS (Table 1) . In fact, little if any was measurable prior to the onset of stationary phase, by which time the level of glucose may have fallen to less inhibitory levels (36) . The presence of 0.3% glucose in the growth medium also totally inhibited production of potential hemolysin (Fig. 9 ). The addition of 0.5% glucose to cells growing in HI-0.3% maltose stopped further production of potential hemolysin measured as sonically releasable hemolysin, so that the amount of potential hemolysin per cell decreased as the cell mass increased (Fig.  10) . The total amount of potential hemolysin Growth  FIG. 9 . Sonically releasable hemolysins during growth with glucose and maltose. Cell density (A) and sonically releasable hemolysin activity (B) were measured during growth in HI-0.3% glucose (A) and HI-0.3% maltose (0). Cells were harvested from 100 ml of medium, suspended in 5 ml of standard buffer, and sonicated at 60 intensity with the model 2 sonicator for 20 min. The sonicates were centrifuged as described in Materials and Methods and assayed for hemolytic activity before (solid lines) and after (dashed lines) adsorption with membranes from 0.25 ml of packed RBC. also decreased slightly (170 HU/ml at 0 h; 140 HU/ml at both 1 and 2 h). Similar results were obtained with 1.0% glucose. These effects of glucose were the same whether potential hemolysin was assayed in the form of SS hemolysin or as RNA-core-stabilized hemolysin (i.e., cells sonicated with RNA-core). A much smaller concentration of glucose (0.03% or 2 x 10-4 M) caused transient repression of potential hemolysin production, unrelieved by cyclic adenosine 3',5'-monophosphate (4 x 10-7 M). In some experiments on transient repression of potential hemolysin production, the cells escaping glucose repression rebounded to make as much potential hemolysin per cell as did the cells of the same age to which glucose had not been added. It seems likely that cells grown in glucose-containing media begin to produce RNA-core SLS in stationary phase (26) , because glucose has been depleted from the me- dium and potential hemolysin formation is no longer repressed.
Extracellular SLS formation did not cease immediately after addition of 1.0% glucose to cells growing in HI-0.3% maltose or in HI, where the effect could be studied over a longer time period (Fig. 11 ). There was a gradual diminution in extracellular hemolysin formation, in contrast to the rapid inhibition of potential hemolysin production. In the resting cell system with HI-0.3% maltose-grown cells, the addition of glucose to cells suspended in Bernheimer's basal medium also did not immediately inhibit the RNA-core SLS increase in titer, a result in agreement with that of others (7) that glucose can be used in the resting cell system. These data support the hypothesis that potential hemolysin is the precursor to SLS. First, if formation of potential hemolysin is prevented by glucose, the formation of extracellular SLS is also prevented. Second, when continued potential hemolysin production is inhibited, the formation of extracellular SLS is diminished. This suggests that potential hemolysin forms a pool from which extracellular SLS is drawn. The LACH has many of the properties of SLS. It exhibits delayed hemolysis and is inhibited by trypan blue. The titer increases slightly, or is stabilized, on incubation in Bernheimer's medium with RNA-core and is decreased by excess RNA-core, possibly through the same mechanism as trypan blue (27) . After incubation with RNA-core, the LACH has the same elution volume from Sephadex G-100 as RNAcore SLS. It seems likely that the hemolytic moiety of LACH is transferred to RNA-core as occurs with other SLS-like hemolysins (23) . The lability of this active cellular hemolysin may possibly be due to weak binding to a carrier molecule, or to a property of the carrier, rather than to any intrinsic difference from RNA-core SLS in the hemolytic moiety.
Taketo and Taketo described an active SLSlike intracellular hemolysin (44) (45) (46) which had properties similar to the SS hemolysin described here. It is unlikely that their hemolysin was the LACH, since it would have been destroyed by sonication and its activity lost during their purification steps. Their active intracellular hemolysin, rather, is similar to SS hemolysin since it (i) was obtained after sonication or homogenization of streptococcal cells, (ii) exhibited a lag in hemolysis, (iii) had a similar pattem of sensitivity to various inhibitors of SLS and SLO, and (iv) was transferable to RNA-core with a resulting smaller size. However, SS hemolysin differs from active intracellular hemolysin in one major property. SS hemolysin is stable to chloroform extraction, whereas the active intracellular hemolysin of Taketo and Taketo was completely destroyed by such treatment. Whether this is due to the difference in bacterial strains, growth conditions, buffer, or pH used is uncertain. The hemolysin which resulted from incubation of active intracellular hemolysin with RNA-core was reported to have characteristics like those reported in this paper for potential hemolysin activated in the presence of RNA-core and for SS hemolysin sonicated or incubated with RNAcore, since all (i) exhibit the general properties of SLS, (ii) show the same elution profile on Sephadex G-100 as SLS, and (iii) show the same susceptibility to Pronase and resistance to trypsin. The RNA-core-dependent increase in hemolytic activity in crude extracts upon incubation reported by Taketo and Taketo (44) is similar to the stabilization of SS hemolysin by RNA-core. They postulated that the increase in titer could be due to the transfer to SLS from a precursor molecule to RNA-core, but did no further experiments to prove that the postulated precursor was other than their active intracellular hemolysin. The increase in titer may have been due to potentiation of hemolysis by RNA-core after the transfer of the hemolytic moiety from SS hemolysin to RNA-core rather than to activation of the precursor. Schwab (38) described an active intracellular hemolysin obtained by prolonged sonication which may be identical with SS hemolysin. Since the activation of potential hemolysin is related to the time and intensity of sonication, the increase in titer over the very prolonged sonication times he used could be explained by the lower intensity of sonication used by Schwab. He suggested that the increase in titer was due to the disassociation of a soluble lysin-inhibitor complex. The finding that muralysin-treated cell supernatant which might be expected to contain the postulated inhibitor did not inhibit SS hemolysin suggests that there is no inhibitor.
The hemolytic activity derived from potential hemolysin bears marked similarity to the hemolytic moiety of RNA-core SLS. First, the increase in titer during activation of potential hemolysin by sonication is enhanced in the presence of RNA-core (and also of streptococcal RNA). Second, both hemolysins are inhibited by excess RNA-core. Third, both are inhibited by trypan blue, but not anti-SLO serum. Fourth, the kinetics of hemolysis by activated potential hemolysin are like those obtained with SLS. Fifth, like SLS (7) and the intracellular hemolysin of Taketo and Taketo (44) , the activated form of potential hemolysin is not destroyed by trypsin. This loss in susceptibility to trypsin on activation of the potential hemolysin might be due either to protection of the tryptic site by RNA-core or to removal of the tryptic site in the activation process. Sixth, both are similarly stable on storage at 0 C. Finally, both RNA-core SLS and the hemolysin activated in the presence of RNA-core have the same elution volume on Sephadex G-100.
Potential hemolysin appears to be a very large, particulate heterogeneous material with a marked tendency to aggregate or precipitate from solution. The particulate nature is probably not an artifact since it is characteristic of potential hemolysin prepared by both muralytic and sonic procedures. Aggregation or precipi- VoL 12, 1975 on October 25, 2017 by guest http://iai.asm.org/ tation occurs after minimal trauma such as storage at 0 C. Whether material in the extracts other than potential hemolysin promotes this aggregation or precipitation is uncertain; relevant to this possibility are the reports that membranes and phospholipids cause aggregation of staphylococcal alpha-toxin into a insoluble form (10) and cause the polymerization of staphylococcal leukocidin (3, 11) . The particulate nature of potential hemolysin and the tendency to aggregate or precipitate from solution may explain the loss of potential hemolysis on Sephadex columns.
A tendency to aggregate or associate with cellular material is apparently characteristic of several bacterial extracellular hemolysins or cytolytic toxins (11) . Staphylococcal alphatoxin aggregates during purification to a larger, but still soluble, particle and can also polymerize to a water-insoluble protein (4, 15, 16) . The F and S components of staphylococcal leukocidin both polymerize in low-ionic-strength solutions (48) . Staphylococcal delta-hemolysin may bind to one or more carrier substances (11) . The Bacillus cereus hemolysin, cereolysin, undergoes loss of activity during ultracentrifugation, freezing, and thawing; it is known to polymerize into an insoluble material (11, 13) . The Bacillus subtilus hemolysin, subtilysin, also aggregates (12) . Our observations that the potential hemolysin and SS hemolysin in group A streptococcal extracts also apparently aggregate extend this characteristic of other bacterial hemolysins to SLS. Taketo and Taketo had earlier suggested that the large size of the SLS-related active intracellular hemolysin might have been due to aggregation (46) .
If activation of potential hemolysin occurs because of exposure of active sites by fragmentation or disaggregation, it would explain the effectiveness of grinding as well as sonication. The results from the sucrose density sedimentation of potential hemolysin and SS hemolysin do suggest that there is some decrease in size during activation. A comparison of Fig. 7 and 8 indicates that there is no peak of SS hemolysin corresponding to the sedimented potential hemolysin at the bottom of the sucrose gradient. The bulk of the SS hemolysin is also slightly shifted toward the top of the gradient as compared to the bulk of the potential hemolysin. The similarity in some properties of potential hemolysin material and activated SS hemolysin does not exclude the possible involvement of transfer of the hemolysin moiety from potential hemolysin material to another cellular carrier such as RNA. For example, if the hemolytic moiety were transferred from potential hemolysin to cellular RNA during sonication, the resultant SS hemolysin might not be precipitated by chloroform.
The fragmentation or disaggregation of potential hemolysin exposing active hemolytic sites, perhaps followed by transfer to another cellular substance, is the most probable explanation of activation. The fact that SS hemolysin after sedimentation at 200,000 x g for 2 h can be "reactivated" by high-speed mixing supports the idea that active hemolysin can remain in a latent state, activatable by exposure of its active site(s). Perhaps the labile cellular hemolysin aggregates into an inactive but potential hemolysin, which can be disaggregated to an active state again. This might account for the apparent rapid inactivation of the labile cellular hemolysin and explain why there is in vivo such a large pool of potential hemolysin and so little of the labile hemolysin. We obtained no evidence that activation frees the hemolysin from a cellular inhibitor as suggested by Schwab (38) . It is of interest, however, that the hemolysin of Streptococcus zymogenes is inhibited by cellular teichoic acid (5).
The temporal relationship of the potential hemolysin to extracellular RNA-core SLS is indicated by the experiments utilizing the effect of glucose on production of both. When glucose is added to the culture media prior to the onset of both RNA-core SLS and potential hemolysin production, it completely prevents formation of both. When the addition of glucose is delayed until after the cells have begun producing both, it stops further formation of potential hemolysin, but only partially decreases formation of RNA-core SLS. These results suggest that (i) in the absence of glucose, SLS is formed as potential hemolysin which is then activated and combines with RNA-core to result in extracellular RNA-core SLS, and (ii) the addition of glucose blocks the formation of potential hemolysin but not the conversion of potential hemolysin to RNA-core SLS. The following sequence may occur during the in vivo formation of SLS. The hemolytic moiety is synthesized either in the latent form of potential hemolysin or as LACH which may aggregate to the latent form. The potential hemolysin may originally be synthesized as part of a large aggregated cellular complex. The potential hemolysin is then activated by cellular mechanisms which may require an energy source (maltose or glucose), Mg2+, and reducing conditions. Whether the activation process is due gregation of an aggregate is presently speculative. The hemolytic moiety of the activated hemolysin is then transferred at the cell surface to an extracellular carrier, such as RNA-core (21, 25, 47) . Alternatively, LACH or the hemolytic moiety is excreted from the cell and is stabilized only when it is immediately protected by a substance such as RNA-core or serum. The extracellular stabilized hemolysin can then bind to RBC (18) or other susceptible cells (30, 37) , where it causes cytolysis. Work in progress to determine the location of these hemolysins should help to differentiate between these possibilities.
